Innovent Biologics, Inc.

OTCPK:IVBX.F Stock Report

Market Cap: US$8.0b

Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:IVBX.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 May 24SellUS$4,683,731De-Chao YuIndividual906,250US$5.17
02 Feb 24BuyUS$7,773,313Capital Research and Management CompanyCompany1,869,776US$4.16
12 Jan 24BuyUS$6,636,262Capital Research and Management CompanyCompany1,292,500US$5.13
05 Jan 24SellUS$17,121,093Capital Research and Management CompanyCompany3,456,000US$4.95
25 Oct 23BuyUS$13,207,557Capital Research and Management CompanyCompany2,249,500US$5.87
17 Oct 23SellUS$2,842,373De-Chao YuIndividual502,961US$5.65
12 Oct 23SellUS$18,282,217Capital Research and Management CompanyCompany3,324,500US$5.50
21 Sep 23SellUS$112,167,374JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany23,185,276US$4.84
12 Sep 23BuyUS$115,993,932JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany25,518,000US$4.55

Insider Trading Volume

Insider Buying: IVBX.F insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of IVBX.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,614,5000.652%
VC/PE Firms89,475,3505.5%
Individual Insiders114,734,8237.05%
General Public652,431,52440.1%
Institutions760,766,49346.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.7%.


Top Shareholders

Top 25 shareholders own 50.24% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.01%
Capital Research and Management Company
114,164,873US$559.7m16.1%0.03%
6.77%
De-Chao Yu
110,253,778US$540.5m0.92%no data
5.5%
SDIC Innovation Investment Management Co., Ltd.
89,475,350US$438.7m0%27.53%
3.56%
The Vanguard Group, Inc.
58,003,862US$284.4m0.25%no data
3.4%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
55,364,540US$271.4m0%43.87%
2.65%
GF Fund Management Co., Ltd.
43,193,655US$211.8m0%0.46%
2.63%
BlackRock, Inc.
42,819,000US$209.9m-0.77%no data
1.85%
Fidelity International Ltd
30,112,499US$147.6m0%0.06%
1.83%
Temasek Holdings (Private) Limited
29,766,000US$145.9m-18.5%0.13%
1.75%
E Fund Management Co., Ltd.
28,473,500US$139.6m0%0.19%
1.66%
Canada Pension Plan Investment Board
27,004,000US$132.4m0%0.08%
1.59%
Harvest Fund Management Co. Ltd.
25,928,788US$127.1m0%0.36%
1.53%
Citigroup Inc.,Banking and Securities Investments
24,932,063US$122.2m0%0.09%
1.48%
Bosera Asset Management Co., Ltd.
24,023,500US$117.8m0%0.59%
1.11%
FMR LLC
18,036,345US$88.4m-14.1%0.01%
0.92%
Norges Bank Investment Management
14,999,175US$73.5m0%0.01%
0.88%
Lav Advanced Management Company Limited
14,276,500US$70.0m0%68.95%
0.62%
China Asset Management Co. Ltd.
10,142,344US$49.7m4.69%0.07%
0.56%
RBC Global Asset Management Inc.
9,115,794US$44.7m0%0.03%
0.54%
Schroder Investment Management Limited
8,747,500US$42.9m0%0.03%
0.54%
Schroder Investment Management North America Inc.
8,744,500US$42.9m16.1%0.13%
0.5%
Invesco Ltd.
8,191,500US$40.2m-0.84%0.01%
0.47%
Polar Capital Holdings Plc
7,655,875US$37.5m0%0.14%
0.45%
LAV Investment Adviser Limited
7,345,000US$36.0m0%no data
0.44%
Strategic Advisers LLC
7,196,529US$35.3m-15.6%0.01%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.